In late 2020, Mandeep Manku made a big contrarian bet.
His hedge fund, Coltrane Asset Management, had already been hit hard when markets plunged because of Covid-19. He decided to swing Coltrane’s portfolio from favouring cheap European companies to betting against tech and other fast-growing companies in the US Markets with so many stocks trading at more than 10 times their revenues, with fervour concentrated in a few sectors, “always end poorly for investors,” Coltrane told clients in a September 2020 presentation.
